Blog

Paradigm Shift: Psilocybin-Assisted Therapy’s New Potential for Treating Complex Symptomology

Psychedelic-assisted therapies have shown great potential to remediate symptomology across a spectrum of mental health conditions. Researchers are beginning to exemplify the “transdiagnostic antidepressant, anxiolytic, and anti-addictive therapeutic potential” of psychedelics by developing crosscutting protocols for addressing a multitude of conditions.

Navigating Complexity: Reflections on the FDA's MDMA-Assisted Therapy Decision and the Future of Psychedelic Medicine

The FDA’s recent decision to decline approval for MDMA-assisted therapy for PTSD, while disappointing, is not the end of the road. The agency’s request for further research serves as a reminder of the hurdles we still face in advancing psychedelic medicine through regulatory channels.

My 3rd Re-Birthday: 10 Integration Techniques I Still Practice Daily

Three years ago, on July 31st, 2021 I would sit up out of a bed in Mexico and my life would be changed in the most positive way. Thanks to VETS, I was able to receive a Foundational Healing Grant for psychedelic-assisted therapy treatment with ibogaine and 5MeO-DMT.

On MDMA, VETS Urges the FDA to Follow the Science, Advance a Revolutionary Treatment for PTSD, and Reduce the Incidence of Veteran Suicide

Anders Halldén: My Journey Back

My name is Anders Halldén and I am a Swedish veteran. I grew up in the Swedish countryside and started my military career as a 14-year-old in the Home Guard. I joined the Swedish military at 19 years old and had a wide and varied 21-year career of Service.